Cargando…

Absence of diabetic retinopathy in a patient who has had diabetes mellitus for 69 years, and inadequate glycemic control: case presentation

The main risk factors for the development and progression of diabetic retinopathy (DR) are chronic hyperglycemia, disease duration and systemic blood pressure. So far chronic hyperglycemia is the strongest evidence concerning the risk of developing DR. However there are some patients with poor metab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Esteves, Jorge, da Rosa, Carolina Maurente, Kramer, Caroline Kaercher, Osowski, Luiz Eduardo, Milano, Stéfano, Canani, Luís Henrique
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2764562/ https://www.ncbi.nlm.nih.gov/pubmed/19825149 http://dx.doi.org/10.1186/1758-5996-1-13

Ejemplares similares

Absence of diabetic retinopathy in a patient who has had diabetes mellitus for 69 years, and inadequate glycemic control: case presentation: response
por: Raman, Rajiv, et al.
Publicado: (2010)

The Role of Glycemic Control and Variability in Diabetic Retinopathy
por: Chatziralli, Irini P.
Publicado: (2017)

Prevalence of diabetic retinopathy in individuals with type 2 diabetes who had recorded diabetic retinopathy from retinal photographs in Catalonia (Spain)
por: Rodriguez-Poncelas, Antonio, et al.
Publicado: (2015)

Glycemic Thresholds for Diabetes-Specific Retinopathy: Implications for diagnostic criteria for diabetes
por: Colagiuri, Stephen, et al.
Publicado: (2011)

Anemia and Diabetic Kidney Disease Had Joint Effect on Diabetic Retinopathy Among Patients With Type 2 Diabetes
por: Wang, Jianyong, et al.
Publicado: (2020)

Effect of diacerein as an add-on to metformin in patients with type 2 diabetes mellitus and inadequate glycemic control
por: Villar, Miriam Méndez-del, et al.
Publicado: (2017)

Aqueous Humor Analyses in Patients with Diabetic Retinopathy Who Had Undergone Panretinal Photocoagulation
por: Kwon, Jin-woo, et al.
Publicado: (2022)

Diabetic Retinopathy Predicts All-Cause Mortality and Cardiovascular Events in Both Type 1 and 2 Diabetes: Meta-analysis of observational studies
por: Kramer, Caroline K., et al.
Publicado: (2011)

The rs2442598 Polymorphism in ANGPT-2 Gene Is Associated With Risk for Diabetic Retinopathy in Patients With Type 1 Diabetes Mellitus From a Brazilian Population
por: Dieter, Cristine, et al.
Publicado: (2021)

Has tamoxifen had its day?
por: Baum, Michael
Publicado: (2002)

A Clinical Conundrum: Intensifying Glycemic Control in the Presence of Advanced Diabetic Retinopathy
por: Ipp, Eli, et al.
Publicado: (2021)

Association Between Serum Magnesium and Glycemic Control, Lipid Profile and Diabetic Retinopathy in Type 1 Diabetes
por: Inácio, Isabel, et al.
Publicado: (2022)

Association Between Serum Magnesium and Glycemic Control, Lipid Profile and Diabetic Retinopathy in Type 1 Diabetes
por: Inácio, Isabel, et al.
Publicado: (2021)

Efficacy of pioglitazone on glycemic control and carotid intima‐media thickness in type 2 diabetes patients with inadequate insulin therapy
por: Yasunari, Eisuke, et al.
Publicado: (2011)

A Randomized Controlled Trial of an Internet-Based Mentoring Program for Type 1 Diabetes Patients with Inadequate Glycemic Control
por: Suh, Sunghwan, et al.
Publicado: (2014)

Inadequate investment on management of diabetes education
por: Abazari, Parvaneh, et al.
Publicado: (2012)

Changes in choroidal thickness and volume are related to urinary albumin excretion in type 2 diabetic patients without retinopathy
por: Farias, Lucas Brandolt, et al.
Publicado: (2018)

The rs2442598 polymorphism in the ANGPT-2 gene is associated with risk for diabetic retinopathy in patients with type 1 diabetes mellitus in a Brazilian population
por: Dieter, Cristine, et al.
Publicado: (2021)

Glycemic variability assessed by continuous glucose monitoring and the risk of diabetic retinopathy in latent autoimmune diabetes of the adult and type 2 diabetes
por: Lu, Jingyi, et al.
Publicado: (2018)

Contrast sensitivity to spatial gratings in moderate and dim light conditions in patients with diabetes in the absence of diabetic retinopathy
por: Safi, Sare, et al.
Publicado: (2017)

Combined effect of glycemic and blood pressure control on diabetic retinopathy among Chinese with type-2 diabetes mellitus
por: Pan, Chen-Wei, et al.
Publicado: (2018)

Benefits of Renin-Angiotensin Blockade on Retinopathy in Type 1 Diabetes Vary With Glycemic Control
por: Harindhanavudhi, Tasma, et al.
Publicado: (2011)

Glycemic Gap as a Useful Surrogate Marker for Glucose Variability and Progression of Diabetic Retinopathy
por: Hsing, Shi-Chue, et al.
Publicado: (2021)

Tolerability and efficacy of glycemic control with saxagliptin in older patients (aged ≥ 65 years) with inadequately controlled type 2 diabetes mellitus
por: Karyekar, Chetan S, et al.
Publicado: (2013)

Efficacy of SGLT2 inhibitors in glycemic control, weight loss and blood pressure reduction: a systematic review and meta-analysis
por: Pinto, Lana Catani, et al.
Publicado: (2015)

Gene polymorphism and plasma levels of miR-155 in diabetic retinopathy
por: Polina, E R, et al.
Publicado: (2019)

Relationship of polymorphisms in microRNAs -124 e -126 with diabetic retinopathy in patients with type 2 diabetes
por: Polina, Evelise Regina, et al.
Publicado: (2015)

The rs1800469 T/T and rs1800470 C/C genotypes of the TGFB1 gene confer protection against diabetic retinopathy in a Southern Brazilian population
por: Costa, Aline Rodrigues, et al.
Publicado: (2023)

The role of progranulin in diabetes and kidney disease
por: Nicoletto, Bruna Bellincanta, et al.
Publicado: (2015)

Colesevelam HCl Improves Glycemic Control and Reduces LDL Cholesterol in Patients With Inadequately Controlled Type 2 Diabetes on Sulfonylurea-Based Therapy
por: Fonseca, Vivian A., et al.
Publicado: (2008)

Association of polymorphisms in the erythropoietin gene with diabetic retinopathy: a case–control study and systematic review with meta-analysis
por: Sesti, Luís Fernando Castagnino, et al.
Publicado: (2022)

Fremanezumab in individuals with chronic migraine who had inadequate response to onabotulinumtoxinA and topiramate or valproic acid
por: Ferrari, Michel D., et al.
Publicado: (2022)

Genetic variability in sodium-glucose cotransporter 2 influences glycemic control and risk for diabetic retinopathy in type 2 diabetes patients
por: Klen, Jasna, et al.
Publicado: (2020)

Effects of Melatonin on Diabetic Neuropathy and Retinopathy
por: Oliveira-Abreu, Klausen, et al.
Publicado: (2021)

Quality of glycemic control has significant impact on myocardial mechanics in type 1 diabetes mellitus
por: Hajdu, Máté, et al.
Publicado: (2022)

Effects of dapagliflozin on serum uric acid levels in hospitalized type 2 diabetic patients with inadequate glycemic control: a randomized controlled trial
por: Hao, Zhaohu, et al.
Publicado: (2018)

Long-Term Cost-Effectiveness Analysis of Once-Weekly Semaglutide versus Dulaglutide in Patients with Type 2 Diabetes with Inadequate Glycemic Control in China
por: Ruan, Zhen, et al.
Publicado: (2022)

Efficacy and safety of sodium-glucose cotransporter-2 inhibitors in type 2 diabetes mellitus with inadequate glycemic control on metformin: a meta-analysis
por: Jingfan, Zhang, et al.
Publicado: (2019)

Continued Reduction in the Prevalence of Retinopathy in Adolescents With Type 1 Diabetes: Role of insulin therapy and glycemic control
por: Downie, Elizabeth, et al.
Publicado: (2011)

The Catalase –262C/T Promoter Polymorphism and Diabetic Complications in Caucasians with Type 2 Diabetes
por: dos Santos, Kátia Gonçalves, et al.
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_eac7n7l44a9834afr1pc2a6uof